GSK vets Wit­ty and Slaoui find new roles in biotech as the great mi­gra­tion con­tin­ues

⇨ An­drew Wit­ty has signed on as a part­ner at Durham, NC-based Hat­teras. “An­drew Wit­ty we be­lieve brings the high­est lev­el of un­der­stand­ing about the phar­ma in­dus­try as a whole,” Hat­teras gen­er­al part­ner Bob In­gram tells End­points News, count­ing off Wit­ty’s lead­ing roles in the glob­al com­mer­cial as well as R&D side of the busi­ness. In­gram says Wit­ty — like­ly the on­ly knight­ed mem­ber of the biotech ven­ture com­mu­ni­ty — is ex­pect­ed to help ad­vise the firm and its biotech com­pa­nies, lend­ing some of his ster­ling Big Phar­ma rep to the or­ga­ni­za­tion as it grows up new com­pa­nies. And, you can add one more new biotech role for ex-GSK CEO. The for­mer phar­ma chief has joined the ad­vi­so­ry board at Syn­thego, a genome en­gi­neer­ing out­fit based in Red­wood City, CA.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER